The Eleventh-Hour Hustle: Whispers of a Deal to Dodge D.C.'s Shutdown Bullet

The Weekend Slow Dance: When Capitol Hill Seeks Answers, Slowly

The Eleventh-Hour Hustle: Washington's Slow Crawl to the Brink

Standoff at the Border: Trump Digs In as Shutdown Looms

The Medicare Part B Late Enrollment Penalty: A Lifelong Burden Many Never See Coming

The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp

The Unseen Momentum: Aadi Bioscience's Remarkable Ascent and the Hope it Carries

Cigna's Unsettling Paradox: Stellar Earnings, Yet the Market Balked

Baxter's Unsettling Quarter: A Deep Dive into Disappointment and a Dimmed Horizon

The Unstoppable Pulse: HCA Healthcare's Surprising Triumph

Turbulence in Healthcare: State's Second-Largest Insurer Sheds 250 Jobs

Healthcare Giant Tower Health Announces Over 500 Layoffs Across New Jersey and Pennsylvania

Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!

Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled

Johnson & Johnson Soars Past Expectations with Stellar Q3 Earnings, Driven by Pharmaceutical and MedTech Growth

Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal

Laura Modi: The Visionary Mom CEO Disrupting America's Baby Formula Empire

Gilead Secures Extended Runway for Blockbuster HIV Drug After Landmark Patent Settlements

The Alarming Pivot: How Telehealth Giants Are Trading Patient Access for Pharmaceutical Profits

Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina

The Biotech & Pharma Services Market: A Decade of Explosive Growth Towards $130 Billion

Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway

GSK Responds to FDA Request: Leucovorin Label Update Confirms No Intent to Market for Autism Spectrum Disorder

Dr. Ashish Jha Dispels Overblown Tylenol-Autism Fears, Advocates for Evidence-Based Calm

Trump Administration Reportedly Poised to Unveil Contentious Link Between Prenatal Tylenol Use and Autism Risk

RFK Jr.'s Vaccine Panel Set to Ignite New Debate on COVID-19 Shot Guidance

The GLP-1 Revolution: Why the Market's Reaction to Novo Nordisk and Eli Lilly is Lagging

Healthcare Titan UnitedHealth Group Poised for Explosive Growth: Why This Giant Is Building a Foundation for Sharp Gains

The Infertility Drugs Market: A Global Surge Towards $6.36 Billion by 2032, Driven by Innovation and Online Access

UnitedHealth's High-Stakes Gambit: Why the Healthcare Giant is Courting Donald Trump Amidst Mounting Regulatory Storms

Cashless Crunch: Hospitals Challenge Star Health Over Service Delays and Deductions

The Future of Mobility: Transport Chairs Market Set to Soar to USD 2.26 Billion by 2032

Healthcare Staffing Giants Brace for Impact as FTC Targets 'Phantom Billing'

CVS's Omnicare Calls in the Experts: A Strategic Move to Revitalize Its Long-Term Care Pharmacy Business

Cervical Cancer Treatment Market Set to Explode, Reaching USD 14.68 Billion by 2034

The Hidden Cost of Commercials: How Deceptive Drug Ads Are Eroding Patient Trust

Breathing Easier: Medical Gas Market Set to Soar to $28.25 Billion by 2032

RFK Jr.'s Tylenol Claims Send Ripples Through Kenvue Stock Amidst Autism Debate

RFK Jr.'s Vaccine Skepticism Ignites Democratic Fury Amidst COVID-19 Shot Access Debates